WHO Raises Global COVID-19 Alert To ‘Very High’ As 1000 Cases Reported Overnight – In China New Cases At Month Low 28/02/2020 Elaine Ruth Fletcher China has reported it’s lowest level of new COVID-19 infections in a month, with just 327 cases over the past 24 hours. At the same time, cases abroad exploded overnight with 1,000 more people reported to be infected with the virus in some 49 countries. Most f new cases were heavily concentrated in the emerging […] Continue reading -> Seven More Countries Report COVID-19 Infections: Wellcome Trust Calls for US$ 10 Billion World Bank Investment 27/02/2020 Elaine Ruth Fletcher For the second day in a row, new COVID-19 cases outside of China exceeded those inside the country on Thursday. According to the latest data Thusday evening, there were now 4,053 cases in 44 countries outside of mainland China, and at least 54 deaths. The biggest hotspots remained Italy, Iran and Korea, but shifting numbers […] Continue reading -> COVID-19 Versus Public Health: New Test Grounds Are Iran, Italy & Korea 24/02/2020 Elaine Ruth Fletcher & Grace Ren With spiraling outbreaks of COVID-19 in 3 countries, Iran, Italy, and Korea, WHO officials warned Monday of growing risks that the epidemic could become a full-fledged pandemic – although Dr Tedros Adhanom Ghebreyesus stepped back from the brink, telling a press briefing on Monday: “Does this virus have pandemic potential? Absolutely it has. Are we […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Three quarters of people with epilepsy in low-income countries do not get treatment 20/06/2019 Editorial team [WHO news release] Three quarters of people living with epilepsy in low-income countries do not get the treatment they need, increasing their risk of dying prematurely and condemning many to a life of stigma. These findings are part of a first-ever global report on Epilepsy, a public health imperative, released today by WHO and two […] Continue reading -> Diarrhoea Can Be More Dangerous Than Bullets To Children During Conflicts, Emergencies 29/03/2019 David Branigan In extended conflicts, “bullets and bombs are not always the deadliest threats to a child’s life,” a new UNICEF report reveals. During such conflicts, children are up to 20 times more likely to die from diarrhoea than violence. As is evidenced by recent outbreaks of cholera in Yemen and Mozambique, conflict and disaster-resilient water, sanitation […] Continue reading -> Two years since world-largest outbreak of acute watery diarrhoea and cholera, Yemen witnessing another sharp increase in reported cases with number of deaths continuing to increase 27/03/2019 Editorial team [WHO News Release] From Geert Cappelaere, UNICEF Regional Director in the Middle East and North Africa and Dr Ahmed Al Mandhari, WHO Regional Director for the Eastern Mediterranean MUSCAT/ AMMAN/CAIRO, 26 March 2019 – “In Yemen, since the beginning of the year until 17 March, nearly 109 000 cases of severe acute watery diarrhoea and suspected […] Continue reading -> WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Seven More Countries Report COVID-19 Infections: Wellcome Trust Calls for US$ 10 Billion World Bank Investment 27/02/2020 Elaine Ruth Fletcher For the second day in a row, new COVID-19 cases outside of China exceeded those inside the country on Thursday. According to the latest data Thusday evening, there were now 4,053 cases in 44 countries outside of mainland China, and at least 54 deaths. The biggest hotspots remained Italy, Iran and Korea, but shifting numbers […] Continue reading -> COVID-19 Versus Public Health: New Test Grounds Are Iran, Italy & Korea 24/02/2020 Elaine Ruth Fletcher & Grace Ren With spiraling outbreaks of COVID-19 in 3 countries, Iran, Italy, and Korea, WHO officials warned Monday of growing risks that the epidemic could become a full-fledged pandemic – although Dr Tedros Adhanom Ghebreyesus stepped back from the brink, telling a press briefing on Monday: “Does this virus have pandemic potential? Absolutely it has. Are we […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Three quarters of people with epilepsy in low-income countries do not get treatment 20/06/2019 Editorial team [WHO news release] Three quarters of people living with epilepsy in low-income countries do not get the treatment they need, increasing their risk of dying prematurely and condemning many to a life of stigma. These findings are part of a first-ever global report on Epilepsy, a public health imperative, released today by WHO and two […] Continue reading -> Diarrhoea Can Be More Dangerous Than Bullets To Children During Conflicts, Emergencies 29/03/2019 David Branigan In extended conflicts, “bullets and bombs are not always the deadliest threats to a child’s life,” a new UNICEF report reveals. During such conflicts, children are up to 20 times more likely to die from diarrhoea than violence. As is evidenced by recent outbreaks of cholera in Yemen and Mozambique, conflict and disaster-resilient water, sanitation […] Continue reading -> Two years since world-largest outbreak of acute watery diarrhoea and cholera, Yemen witnessing another sharp increase in reported cases with number of deaths continuing to increase 27/03/2019 Editorial team [WHO News Release] From Geert Cappelaere, UNICEF Regional Director in the Middle East and North Africa and Dr Ahmed Al Mandhari, WHO Regional Director for the Eastern Mediterranean MUSCAT/ AMMAN/CAIRO, 26 March 2019 – “In Yemen, since the beginning of the year until 17 March, nearly 109 000 cases of severe acute watery diarrhoea and suspected […] Continue reading -> WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Versus Public Health: New Test Grounds Are Iran, Italy & Korea 24/02/2020 Elaine Ruth Fletcher & Grace Ren With spiraling outbreaks of COVID-19 in 3 countries, Iran, Italy, and Korea, WHO officials warned Monday of growing risks that the epidemic could become a full-fledged pandemic – although Dr Tedros Adhanom Ghebreyesus stepped back from the brink, telling a press briefing on Monday: “Does this virus have pandemic potential? Absolutely it has. Are we […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Three quarters of people with epilepsy in low-income countries do not get treatment 20/06/2019 Editorial team [WHO news release] Three quarters of people living with epilepsy in low-income countries do not get the treatment they need, increasing their risk of dying prematurely and condemning many to a life of stigma. These findings are part of a first-ever global report on Epilepsy, a public health imperative, released today by WHO and two […] Continue reading -> Diarrhoea Can Be More Dangerous Than Bullets To Children During Conflicts, Emergencies 29/03/2019 David Branigan In extended conflicts, “bullets and bombs are not always the deadliest threats to a child’s life,” a new UNICEF report reveals. During such conflicts, children are up to 20 times more likely to die from diarrhoea than violence. As is evidenced by recent outbreaks of cholera in Yemen and Mozambique, conflict and disaster-resilient water, sanitation […] Continue reading -> Two years since world-largest outbreak of acute watery diarrhoea and cholera, Yemen witnessing another sharp increase in reported cases with number of deaths continuing to increase 27/03/2019 Editorial team [WHO News Release] From Geert Cappelaere, UNICEF Regional Director in the Middle East and North Africa and Dr Ahmed Al Mandhari, WHO Regional Director for the Eastern Mediterranean MUSCAT/ AMMAN/CAIRO, 26 March 2019 – “In Yemen, since the beginning of the year until 17 March, nearly 109 000 cases of severe acute watery diarrhoea and suspected […] Continue reading -> WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Three quarters of people with epilepsy in low-income countries do not get treatment 20/06/2019 Editorial team [WHO news release] Three quarters of people living with epilepsy in low-income countries do not get the treatment they need, increasing their risk of dying prematurely and condemning many to a life of stigma. These findings are part of a first-ever global report on Epilepsy, a public health imperative, released today by WHO and two […] Continue reading -> Diarrhoea Can Be More Dangerous Than Bullets To Children During Conflicts, Emergencies 29/03/2019 David Branigan In extended conflicts, “bullets and bombs are not always the deadliest threats to a child’s life,” a new UNICEF report reveals. During such conflicts, children are up to 20 times more likely to die from diarrhoea than violence. As is evidenced by recent outbreaks of cholera in Yemen and Mozambique, conflict and disaster-resilient water, sanitation […] Continue reading -> Two years since world-largest outbreak of acute watery diarrhoea and cholera, Yemen witnessing another sharp increase in reported cases with number of deaths continuing to increase 27/03/2019 Editorial team [WHO News Release] From Geert Cappelaere, UNICEF Regional Director in the Middle East and North Africa and Dr Ahmed Al Mandhari, WHO Regional Director for the Eastern Mediterranean MUSCAT/ AMMAN/CAIRO, 26 March 2019 – “In Yemen, since the beginning of the year until 17 March, nearly 109 000 cases of severe acute watery diarrhoea and suspected […] Continue reading -> WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Three quarters of people with epilepsy in low-income countries do not get treatment 20/06/2019 Editorial team [WHO news release] Three quarters of people living with epilepsy in low-income countries do not get the treatment they need, increasing their risk of dying prematurely and condemning many to a life of stigma. These findings are part of a first-ever global report on Epilepsy, a public health imperative, released today by WHO and two […] Continue reading -> Diarrhoea Can Be More Dangerous Than Bullets To Children During Conflicts, Emergencies 29/03/2019 David Branigan In extended conflicts, “bullets and bombs are not always the deadliest threats to a child’s life,” a new UNICEF report reveals. During such conflicts, children are up to 20 times more likely to die from diarrhoea than violence. As is evidenced by recent outbreaks of cholera in Yemen and Mozambique, conflict and disaster-resilient water, sanitation […] Continue reading -> Two years since world-largest outbreak of acute watery diarrhoea and cholera, Yemen witnessing another sharp increase in reported cases with number of deaths continuing to increase 27/03/2019 Editorial team [WHO News Release] From Geert Cappelaere, UNICEF Regional Director in the Middle East and North Africa and Dr Ahmed Al Mandhari, WHO Regional Director for the Eastern Mediterranean MUSCAT/ AMMAN/CAIRO, 26 March 2019 – “In Yemen, since the beginning of the year until 17 March, nearly 109 000 cases of severe acute watery diarrhoea and suspected […] Continue reading -> WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Diarrhoea Can Be More Dangerous Than Bullets To Children During Conflicts, Emergencies 29/03/2019 David Branigan In extended conflicts, “bullets and bombs are not always the deadliest threats to a child’s life,” a new UNICEF report reveals. During such conflicts, children are up to 20 times more likely to die from diarrhoea than violence. As is evidenced by recent outbreaks of cholera in Yemen and Mozambique, conflict and disaster-resilient water, sanitation […] Continue reading -> Two years since world-largest outbreak of acute watery diarrhoea and cholera, Yemen witnessing another sharp increase in reported cases with number of deaths continuing to increase 27/03/2019 Editorial team [WHO News Release] From Geert Cappelaere, UNICEF Regional Director in the Middle East and North Africa and Dr Ahmed Al Mandhari, WHO Regional Director for the Eastern Mediterranean MUSCAT/ AMMAN/CAIRO, 26 March 2019 – “In Yemen, since the beginning of the year until 17 March, nearly 109 000 cases of severe acute watery diarrhoea and suspected […] Continue reading -> WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Two years since world-largest outbreak of acute watery diarrhoea and cholera, Yemen witnessing another sharp increase in reported cases with number of deaths continuing to increase 27/03/2019 Editorial team [WHO News Release] From Geert Cappelaere, UNICEF Regional Director in the Middle East and North Africa and Dr Ahmed Al Mandhari, WHO Regional Director for the Eastern Mediterranean MUSCAT/ AMMAN/CAIRO, 26 March 2019 – “In Yemen, since the beginning of the year until 17 March, nearly 109 000 cases of severe acute watery diarrhoea and suspected […] Continue reading -> WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Posts navigation Older postsNewer posts